Private Equity in the Cross Hairs: Navigating Increasing Antitrust Scrutiny of Private Equity Deals in Health Care (On-Demand Webinar)
Date: 05/22/24
Closed captions are available.
Overview: Antitrust enforcers at DOJ and FTC have signaled that private equity (PE) firms’ transactions in health care are likely to receive much greater antitrust scrutiny going forward. According to enforcers, the proliferation of PE deals in the U.S. has caused a range of harms, including reduced health care quality and access, as well as increasing health care costs. Parties to health care deals involving PE firms should consider this new enforcement landscape when planning deals.
Learning Objectives:
- How parties can proactively prepare for heighted antitrust scrutiny of private equity deals in health care.
- The legal and economic theories antitrust enforcers may use to challenge PE deals in health care.
- Questions parties involved in PE deals are likely to get from antitrust enforcers going forward.
Speaker Information:
Herbert Allen, Partner, Honigman LLP
Emily Walden, Economist, NERA
Bryn Williams, First Assistant Attorney General, Antitrust Unit, Colorado Attorney General’s Office
Credit Information
CLE: The maximum number of credits available for ON DEMAND is 1.5 for a 60-minute state and 1.8 for a 50-minute state. Please note that the actual number of credits may vary from state to state.
CPE: CPE credits are not available for on-demand.
CCB: The Compliance Certification Board (CCB)® has approved this event for up to 1.8 NON LIVE CCB CEUs based on a 50-minute hour. Continuing Education Units are awarded based on individual attendance records. Granting of prior approval in no way constitutes endorsement by CCB of this event content or of the event sponsor.
This self-study course will be available for purchase for approximately one year after the recording date. State rules on duration of eligibility for CLE-credits differ, so please check with your state before purchasing self study offerings.